FDA Approves New Drug for Generalized Myasthenia Gravis
Zilucoplan is the first once-daily, subcutaneous, self-administered, targeted C5 complement inhibitor for adults with gMG who are AChR antibody positive.
Source: medscape.com
Page 9 - Self Administration News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Self Administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Self Administration Today - Breaking & Trending Today
Addex mGlu2PAM Demonstrates Potential in Substance Use Disorder
Data published in Neuropharmacology shows mGlu2 PAMs attenuate oxycodone use and potential as a novel treatment for opioid use disorder Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 24, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced data showing that administration of a metabotropic glutamate 2 (mGlu2) positive allosteric modulator significantly
Source: yahoo.com
Do-It-Yourself Medications: Self-Injected Drugs on the Rise
'We have people taking two or three different injectable drugs every other week.'
Source: medscape.com
Context Update: Northwestern Syria | April 2023 - Syrian Arab Republic
Analysis in English on Syrian Arab Republic and 1 other country about Peacekeeping and Peacebuilding, Protection and Human Rights, Earthquake and more; published on 10 May 2023 by iMMAP
Source: reliefweb.int
Report to Congress on Syria and U.S. Policy
The following is the Congressional Research Service Feb. 24, 2023, In Focus report: Syria and U.S. Policy. From the report Since 2011, conflict between the government of Syrian President Bashar al Asad and opposition forces seeking his removal has displaced roughly half of the country’s population and killed over half a million people. Five countries […]
Source: usni.org